European Monitoring Centre for Drugs and Drug Addiction (EMCDDA)

The European Monitoring Centre for Drugs and Drug Addiction (EMCDDA) was established in 1993. Inaugurated in Lisbon in 1995, it is one of the EU’s decentralised agencies. The EMCDDA exists to provide the EU and its Member States with a factual overview of European drug problems and a solid evidence base to support the drugs debate. Today it offers policymakers the data they need for drawing up informed drug laws and strategies. It also helps professionals and practitioners working in the field pinpoint best practice and new areas of research.

Mission

The EMCDDA was set up to provide 'factual, objective, reliable and comparable information concerning drugs, drug addiction and their consequences'

How wastewater monitoring can boost preparedness for new health threats

Created by
EMCDDA

Objective: to explore wastewater analysis as a methodology contributing to EU preparedness and response

Background: COVID-19 has raised the attention of Europe, and globally, on the importance of readiness towards potential emergencies. Improved and innovative monitoring methodologies are at the core of the research-based actions taken to respond to potential threats.

Prevention Topics Page

Created by
EMCDDA

Drug prevention approaches range from those that target society as a whole (environmental and universal prevention) to interventions focusing on at-risk individuals (indicated prevention).

The main challenges are in matching these different strategies to target groups and contexts and ensuring that they are evidence-based and have sufficient population coverage.

European Drugs Winter School 2023

Online,

Illicit drugs in Europe: demand, supply and public policies

Special Focus on Displaced Populations and Drug Related Issues

Our two week online Winter School (13th to 24th of February 2023) prepares professionals and students to meet the complex policy challenges that face Europe and the World in the field of drugs.

Recreational use of nitrous oxide — a growing concern for Europe

Published by
EMCDDA
Publication Date

Summary

The purpose of this report is to examine the current situation, risks and responses to the recreational use of nitrous oxide in Europe. To support this, the report also provides a state-of-the-art review of the chemistry, pharmacology and toxicology of the gas. It is intended for policymakers and practitioners.

The report is structured as follows:

EMCDDA webinar: How wastewater monitoring can boost preparedness for new health threats

Online,

Objective: to explore wastewater analysis as a methodology contributing to EU preparedness and response

Background: COVID-19 has raised the attention of Europe, and globally, on the importance of readiness towards potential emergencies. Improved and innovative monitoring methodologies are at the core of the research-based actions taken to respond to potential threats.

Registration opens for European Drugs Winter and Summer Schools 2023

The EMCDDA and the University Institute of Lisbon (ISCTE-IUL) are delighted to open registration today for two upcoming joint events in 2023: the European Drugs Winter School (EDWS) and the European Drugs Summer School (EDSS) (1)(2). EDWS: 13–24 February 2023 (online): This year, the theme will be ‘Displaced populations and drug- related issues’, with one full day dedicated to this topic. The two-week course will feature live lunchtime lectures with experts and practitioners, followed by

Preparing for the future — applying a foresight approach in the drugs field

Created by
EMCDDA

Objective: This webinar marks the official launch of the EMCDDA’s foresight toolkit for the drugs field entitled How to run a trends workshop in the drugs field. The event also aims to promote a foresight approach and increase foresight literacy among the EMCDDA’s stakeholders and to take stock of current initiatives in this area and reflect on possible ways forward.